19 June 2013
Keywords: ec, oks, wyeth, refacto, ma, variation, drug
Article | 16 March 2009
US drug major Wyeth' UK subsidiary has received a positive decision from the European Commission for a variation of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2009
18 June 2013
© 2013 thepharmaletter.com